Paul Saladino· MD
And we sort of saw that with the BP 5000 data. There was this blueprint 5000 data that he did a study on. A lot of it was hidden. He never actually released the data.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And we sort of saw that with the BP 5000 data. There was this blueprint 5000 data that he did a study on. A lot of it was hidden. He never actually released the data.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.